The health ministry on Monday announced a woman had died due to myocarditis, which is known to be a rare side effect of the Pfizer-BioNTech COVID-19 vaccine. Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heartbeat rhythms. The health ministry did not provide the woman’s age. Pfizer in New Zealand did not immediately reply to an emailed request for comment.
Moderna Inc’s COVID-19 vaccine contamination woes in Japan have widened with another million doses being suspended after foreign substances were found in more batches and two people died following shots from affected lots.
Category:
Pandemic
Latest
U.S. reports world’s first deer with COVID-19
India’s coronavirus vaccine supply jumps, raising hopes of export
India’s daily vaccinations surpassed 10 million doses on Friday, with national vaccine production more than doubling since April and set to rise again in the coming weeks. New production lines have been set up, a vaccine developed by Cadila Healthcare won recent approval, and commercial production of Russia’s Sputnik V is starting in India.
The Serum Institute of India (SII), the world’s biggest vaccine maker, is now producing about 150 million doses a month of its version of the AstraZeneca shot, more than twice its April output of about 65 million, a source with knowledge of the matter said.
Bharat Bio working on nasal vaccine
Krishna Ella, chairman and MD, Bharat Biotechsaid said his firm is setting up two more facilities for manufacturing vaccines, including for Covaxin.
India could authorise COVID-19 vaccines in weeks, 300 million on priority list
Indian Prime Minister Narendra Modi’s government has identified 300 million people, including healthcare workers, policemen, and citizens above the age of 50, who would be administered a vaccine on a priority basis, health secretary Rajesh Bhushan said.
“Every single Indian who needs to be vaccinated, will be vaccinated,” Bhushan said, adding that the government expected the vaccination process to take over a year to complete.
India’s COVID-19 caseload rises to 97.35 lakh; recoveries cross 92 lakh
The number of people who have recuperated from the disease surged to 92,15,581, pushing the national recovery rate to 94.66 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent.
There are 3,78,909 active coronavirus infections in the country now which comprises 3.89 per cent of the total caseload, the data stated.
The COVID-19 active caseload remained below four lakh for the third consecutive day.
Back pain could be pancreatic cancer’s first sign: Expert
A study published in the monthly medical journal JAMA Internal Medicine found that there is a strong link between sitting for long hours, leading a sedentary lifestyle and death due to cancer.
British grandma is first in world to get Pfizer vaccine outside trial
Britain is the worst-hit European country from COVID-19, with over 61,000 deaths, but Prime Minister Boris Johnson hopes to turn the tide against the disease by rolling out the Pfizer/BioNTech vaccine before the United States or European Union.
Ambani hints at 5G rollout in second half of 2021
5G is the 5th generation mobile network that enables connecting virtually everyone and everything together including machines, objects, and devices.
“We are creating compelling home-grown solutions in education, healthcare, agriculture, infrastructure, financial services and new commerce,” Mukesh Ambani said. “Each of these solutions, once proven in India, will be offered to the rest of the world to address global challenges.”
French insurers to freeze premiums for sectors hardest hit by virus
Under pressure from French Finance Minister Bruno Le Maire,insurers faced the prospect of being hit by a 1.2 billion euro ($1.45 billion) tax if they did not offer to keep premiums steady next year.
Le Maire, who had been concerned some insurers were preparing to hike premiums, said the freeze would benefit hotels, restaurants and bars as well as firms in the tourism, sports, culture and events industries.
PM says mobile technology to be used for COVID-19 vaccination drive
“It is also with the help of mobile technology that we will embark on one of the world’s largest COVID-19 vaccination drive,” he said.
He did not provide details.
Explainer: I just got a COVID-19 vaccine. Now what?
Since there is no evidence that the immunization prevents transmission of the virus – and no vaccine is 100% effective – scientists call for continued vigilance, including mask-wearing, hand-washing and social distancing
Aon report highlights a path toward “The New Better” in wake of COVID-19 Pandemic
Study shows global shift in attitudes of leading organizations toward long-tail risks and the impacts on how society will continue to work, travel and convene
More than 130 organizations across multiple industries and four continents in 10 cities participated in coalition meetings, sharing best practices and outlining new priorities to accelerate economic recovery